Eli Lilly and Company News - August 19, 2026
Lilly's GLP-1 Bet on Depression Could Open a Massive New Market — But Can Investors Price In a Drug That Won't Exist Until 2028?
Shares of Eli Lilly surged 5.0% to $1,287.23 on August 19, pushing past the previous session's close of $1,225.73, as investors continued to bid up the stock...
🟢 Eli Lilly is trading 5.34% up today after strong Q2 results and higher 2026 guidance
Eli Lilly is trading 5.34% up now at $1291.24, as investors continue rewarding strong second-quarter results and a higher 2026 revenue outlook. -...
🟢 Eli Lilly is trading 4.5% up today after strong Q2 earnings and raised 2026 guidance
Eli Lilly's stock surged 4.5% to $1287.23 today, driven by continued investor enthusiasm following robust second-quarter earnings where revenue jumped 48%. -...